ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
81.20
+1.07 (1.34%)
At close: Jun 9, 2026, 4:00 PM EDT
80.01
-1.19 (-1.47%)
After-hours: Jun 9, 2026, 6:56 PM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, ANI Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $109.88. The average 1-year stock price forecast is 35.32% higher than the current stock price, while the lowest is $90 (+10.84%) and the highest is $124 (+52.71%).
Price Target: $109.88 (+35.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +23.15% | May 20, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $124 | Buy | Reiterates | $124 | +52.71% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $121 | Buy | Reiterates | $121 | +49.01% | May 8, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
1.12B
from 883.37M
Increased by 27.07%
Revenue Next Year
1.25B
from 1.12B
Increased by 11.22%
EPS This Year
9.40
from 7.89
Increased by 19.08%
EPS Next Year
10.61
from 9.40
Increased by 12.94%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.2B | ||
| Avg | 1.1B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.7% | ||
| Avg | 27.1% | ||
| Low | 25.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 9.40 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 19.1% | ||
| Low | - |